4
Changes in Ownership
Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-22-036243
Options or other derivatives
- Chief Development Officer acquired 625,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Matkovits Theresa Chief Development Officer | 2022-12-20 | Grant or award · Stock Option (right to Buy) | +625,000 | 625,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…